Nurse Practitioner, Family · Oklahoma City, OK
NPI
1558830968
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6613 N Meridian Ave
Oklahoma City, OK, 73116
Phone (405) 603-8450
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
794 services
Medicare patients, 2024
115
Average age 54
Drug cost, 2024
$1.3M
3,767 prescriptions
Company payments, 2025
$3,509
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lindi C Ciglar was code 99347 (home e&m - new and established), 386 times for 47 patients. In total Lindi C Ciglar billed 794 services in 11 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99347 Home E&M - New and Established | Office | 386 | 47 | $19.85 | $7,663 |
| 99212 Office E&M - Established | Office | 136 | 49 | $25.95 | $3,530 |
| 99213 Office E&M - Established | Office | 132 | 75 | $45.18 | $5,963 |
| 99441 Telephone Services | Office | 41 | 33 | $1.92 | $78.61 |
| 99214 Office E&M - Established | Office | 34 | 25 | $69.89 | $2,376 |
| 99348 Home E&M - New and Established | Office | 27 | 19 | $48.55 | $1,311 |
By year: 2022 $23K for 694 services; 2023 $21K for 782 services; 2024 $22K for 794 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lindi C Ciglar prescribed most often to Medicare patients was Risperidone, with 290 prescriptions and refills. In total Lindi C Ciglar wrote 3,767 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Risperidone Generic | 290 | 373 | 45 | $4,540 |
| Trazodone Hcl Generic | 214 | 279 | 38 | $2,173 |
| Olanzapine Generic | 190 | 256 | 25 | $4,234 |
| Aripiprazole Generic | 185 | 229 | 34 | $11K |
| Lamotrigine Generic | 174 | 240 | 30 | $2,503 |
| Vraylar Cariprazine Hcl | 156 | 156 | 14 | $191K |
| Sertraline Hcl Generic | 151 | 197 | 25 | $2,082 |
| Hydroxyzine Pamoate Generic | 122 | 154 | 27 | $1,538 |
| Bupropion Xl Bupropion Hcl | 121 | 165 | 18 | $2,659 |
| Topiramate Generic | 120 | 134 | 17 | $1,140 |
| Quetiapine Fumarate Generic | 113 | 163 | 16 | $2,496 |
| Lithium Carbonate Generic | 102 | 116 | 15 | $1,093 |
| Duloxetine Hcl Generic | 99 | 165 | 19 | $2,353 |
| Clonazepam Generic | 85 | 85 | 15 | $824 |
| Buspirone Hcl Generic | 80 | 128 | 13 | $1,220 |
Brand drugs: 414 claims; generic drugs: 3,353 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lindi C Ciglar $3,509 ($3,509 in general payments such as food, travel and fees) from 16 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $576.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $576 |
| Teva Pharmaceuticals USA, Inc. TEVA | 29 | $526 |
| Vanda Pharmaceuticals Inc. VNDA | 21 | $400 |
| Alkermes, Inc. ALKS | 14 | $302 |
| Neurocrine BioSciences, Inc. NBIX | 22 | $292 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 17 | $272 |
| Janssen Pharmaceuticals, Inc JNJ | 17 | $251 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 15 | $242 |
| Abbvie Inc. ABBV | 19 | $187 |
| Lundbeck LLC | 5 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.